124 related articles for article (PubMed ID: 15228543)
1. In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus.
Schneider T; Senn MM; Berger-Bächi B; Tossi A; Sahl HG; Wiedemann I
Mol Microbiol; 2004 Jul; 53(2):675-85. PubMed ID: 15228543
[TBL] [Abstract][Full Text] [Related]
2. Identification and in vitro analysis of the GatD/MurT enzyme-complex catalyzing lipid II amidation in Staphylococcus aureus.
Münch D; Roemer T; Lee SH; Engeser M; Sahl HG; Schneider T
PLoS Pathog; 2012 Jan; 8(1):e1002509. PubMed ID: 22291598
[TBL] [Abstract][Full Text] [Related]
3. REDOR constraints on the peptidoglycan lattice architecture of Staphylococcus aureus and its FemA mutant.
Singh M; Kim SJ; Sharif S; Preobrazhenskaya M; Schaefer J
Biochim Biophys Acta; 2015 Jan; 1848(1 Pt B):363-8. PubMed ID: 24990251
[TBL] [Abstract][Full Text] [Related]
4. Structure-based modeling and dynamics of MurM, a Streptococcus pneumoniae penicillin resistance determinant present at the cytoplasmic membrane.
York A; Lloyd AJ; Del Genio CI; Shearer J; Hinxman KJ; Fritz K; Fulop V; Dowson CG; Khalid S; Roper DI
Structure; 2021 Jul; 29(7):731-742.e6. PubMed ID: 33740396
[TBL] [Abstract][Full Text] [Related]
5. A glyS T-box riboswitch with species-specific structural features responding to both proteinogenic and nonproteinogenic tRNAGly isoacceptors.
Apostolidi M; Saad NY; Drainas D; Pournaras S; Becker HD; Stathopoulos C
RNA; 2015 Oct; 21(10):1790-806. PubMed ID: 26276802
[TBL] [Abstract][Full Text] [Related]
6. Cross-link formation and peptidoglycan lattice assembly in the FemA mutant of Staphylococcus aureus.
Kim SJ; Singh M; Sharif S; Schaefer J
Biochemistry; 2014 Mar; 53(9):1420-7. PubMed ID: 24517508
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide mutant profiling predicts the mechanism of a Lipid II binding antibiotic.
Santiago M; Lee W; Fayad AA; Coe KA; Rajagopal M; Do T; Hennessen F; Srisuknimit V; Müller R; Meredith TC; Walker S
Nat Chem Biol; 2018 Jun; 14(6):601-608. PubMed ID: 29662210
[TBL] [Abstract][Full Text] [Related]
8. Assembly of the monomer unit of bacterial peptidoglycan.
van Heijenoort J
Cell Mol Life Sci; 1998 Apr; 54(4):300-4. PubMed ID: 9614964
[TBL] [Abstract][Full Text] [Related]
9. Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II.
Schneider T; Kruse T; Wimmer R; Wiedemann I; Sass V; Pag U; Jansen A; Nielsen AK; Mygind PH; Raventós DS; Neve S; Ravn B; Bonvin AM; De Maria L; Andersen AS; Gammelgaard LK; Sahl HG; Kristensen HH
Science; 2010 May; 328(5982):1168-72. PubMed ID: 20508130
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic synthesis of lipid II and analogues.
Huang LY; Huang SH; Chang YC; Cheng WC; Cheng TJ; Wong CH
Angew Chem Int Ed Engl; 2014 Jul; 53(31):8060-5. PubMed ID: 24990652
[TBL] [Abstract][Full Text] [Related]
11. Forming cross-linked peptidoglycan from synthetic gram-negative Lipid II.
Lebar MD; Lupoli TJ; Tsukamoto H; May JM; Walker S; Kahne D
J Am Chem Soc; 2013 Mar; 135(12):4632-5. PubMed ID: 23480167
[TBL] [Abstract][Full Text] [Related]
12. The lipopeptide antibiotic Friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate.
Schneider T; Gries K; Josten M; Wiedemann I; Pelzer S; Labischinski H; Sahl HG
Antimicrob Agents Chemother; 2009 Apr; 53(4):1610-8. PubMed ID: 19164139
[TBL] [Abstract][Full Text] [Related]
13. Structural and enzymatic analysis of TarM glycosyltransferase from Staphylococcus aureus reveals an oligomeric protein specific for the glycosylation of wall teichoic acid.
Koç C; Gerlach D; Beck S; Peschel A; Xia G; Stehle T
J Biol Chem; 2015 Apr; 290(15):9874-85. PubMed ID: 25697358
[TBL] [Abstract][Full Text] [Related]
14. In vitro peptidoglycan synthesis assay with lipid II substrate.
Biboy J; Bui NK; Vollmer W
Methods Mol Biol; 2013; 966():273-88. PubMed ID: 23299741
[TBL] [Abstract][Full Text] [Related]
15. Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids.
Brown S; Xia G; Luhachack LG; Campbell J; Meredith TC; Chen C; Winstel V; Gekeler C; Irazoqui JE; Peschel A; Walker S
Proc Natl Acad Sci U S A; 2012 Nov; 109(46):18909-14. PubMed ID: 23027967
[TBL] [Abstract][Full Text] [Related]
16. An oldie but a goodie - cell wall biosynthesis as antibiotic target pathway.
Schneider T; Sahl HG
Int J Med Microbiol; 2010 Feb; 300(2-3):161-9. PubMed ID: 20005776
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcus aureus infections.
Lowy FD
N Engl J Med; 1998 Aug; 339(8):520-32. PubMed ID: 9709046
[No Abstract] [Full Text] [Related]
18. Molecular docking-based screening of methicillin-resistant
Akkiraju AG; Badugu A; Das A; Sagurthi SR
Bioinformation; 2023; 19(11):1035-1042. PubMed ID: 38046517
[TBL] [Abstract][Full Text] [Related]
19. Cloning, Purification, and Biophysical Characterization of FemB Protein from Methicillin-Resistant Staphylococcus aureus and Inhibitors Screening.
Akkiraju AG; Atcha KR; Sagurthi SR
Appl Biochem Biotechnol; 2023 Nov; ():. PubMed ID: 37991634
[TBL] [Abstract][Full Text] [Related]
20. Teicoplanin associated gene
Habib G; Gul H; Ahmad P; Hayat A; Rehman MU; Mohamed Moussa I; Elansary HO
Front Microbiol; 2023; 14():1241995. PubMed ID: 37901830
[No Abstract] [Full Text] [Related]
[Next] [New Search]
